We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+35.35%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
AUM
$12.8B
AUM Growth
+$3.79B
Cap. Flow
+$2.28B
Cap. Flow %
17.8%
Top 10 Hldgs %
15.6%
Holding
2,120
New
741
Increased
362
Reduced
312
Closed
513

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 3.1%
2 Technology 2.68%
3 Healthcare 2.33%
4 Communication Services 1.06%
5 Financials 0.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KALV
376
CALL
DELISTED
KalVista Pharmaceuticals
KALV
$7.08M 0.06%
+581,600
New +$8.04M
STX icon
377
CALL
Seagate
STX
$193B
$7.08M 0.06%
+30,000
New +$5.12M
EOSE icon
378
Eos Energy Enterprises
EOSE
$1.23B
$7.07M 0.06%
+620,720
New +$4.25M
SGRY icon
379
PUT
Surgery Partners
SGRY
$2.06B
$7.03M 0.05%
325,000
KVUE icon
380
PUT
Kenvue
KVUE
$37B
$7.03M 0.05%
+433,300
New +$8.85M
PEP icon
381
CALL
PepsiCo
PEP
$186B
$7.02M 0.05%
+50,000
New +$7.14M
ADSK icon
382
PUT
Autodesk
ADSK
$44.3B
$7.02M 0.05%
+22,100
New +$6.73M
NUVB icon
383
CALL
Nuvation Bio
NUVB
$2.24B
$7.01M 0.05%
1,893,800
+928,400
+96% +$2.53M
DDOG icon
384
Datadog
DDOG
$87.9B
$6.98M 0.05%
+49,000
New +$6.75M
PL icon
385
CALL
Planet Labs
PL
$7.3B
$6.91M 0.05%
532,500
+182,500
+52% +$1.41M
RKT icon
386
CALL
Rocket Companies
RKT
$36.9B
$6.91M 0.05%
356,500
+290,000
+436% +$5.06M
APLS
387
DELISTED
Apellis Pharmaceuticals
APLS
$6.9M 0.05%
305,000
+74,112
+32% +$1.73M
ALNY icon
388
CALL
Alnylam Pharmaceuticals
ALNY
$36.3B
$6.84M 0.05%
15,000
+5,000
+50% +$2.04M
W icon
389
Wayfair
W
$11.1B
$6.8M 0.05%
76,100
-8,900
-10% -$652K
HOLX
390
DELISTED
Hologic
HOLX
$6.74M 0.05%
+99,811
New +$6.63M
PG icon
391
PUT
Procter & Gamble
PG
$343B
$6.71M 0.05%
43,700
+23,700
+119% +$3.7M
RGEN icon
392
PUT
Repligen
RGEN
$7.44B
$6.68M 0.05%
50,000
SMCI icon
393
Super Micro Computer
SMCI
$19.5B
$6.67M 0.05%
139,200
+53,200
+62% +$2.54M
KVYO icon
394
CALL
Klaviyo
KVYO
$4.91B
$6.65M 0.05%
+240,000
New +$7.75M
PDD icon
395
Pinduoduo
PDD
$118B
$6.6M 0.05%
49,947
+47,247
+1,750% +$5.59M
TECH icon
396
PUT
Bio-Techne
TECH
$11.2B
$6.54M 0.05%
+117,500
New +$6.29M
AZN icon
397
AstraZeneca
AZN
$263B
$6.51M 0.05%
42,450
+14,451
+52% +$2.19M
HAL icon
398
PUT
Halliburton
HAL
$27.9B
$6.5M 0.05%
+264,100
New +$5.84M
EME icon
399
PUT
Emcor
EME
$33.1B
$6.5M 0.05%
10,000
MSTR icon
400
PUT
Strategy Inc
MSTR
$33.5B
$6.44M 0.05%
+20,000
New +$7.42M

Similar funds

Caption Management's Q3 2025 Portfolio in Review

As of Q3 2025, Caption Management held 2,120 positions worth $12.8B, up 42% from $9.03B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Caption Management deployed $2.28B of net new capital in Q3 2025, opening 741 new positions and adding to 362 existing holdings. Its largest new stake was Amazon: 575,000 shares worth $126M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 3.1% of assets, up from 2.5% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Insmed, an estimated $25.8M trimmed.

  • Caption Management's largest Q3 2025 buy was Amazon: 575,000 shares worth $126M.
  • Caption Management added most to Sable Offshore Corp in Q3 2025, an estimated $34.9M increase.
  • Caption Management's biggest Q3 2025 reduction was Insmed, cutting an estimated $25.8M.
  • Caption Management fully exited Skechers in Q3 2025, selling an estimated $20.1M.
  • Caption Management's ten largest holdings make up 16% of its $12.8B portfolio in Q3 2025.
  • Caption Management opened 741 new positions and closed 513 in Q3 2025.
  • Caption Management's portfolio value rose 42% quarter-over-quarter to $12.8B.

Based on Caption Management's 13F filing for Q3 2025, filed 14 Nov 2025.